Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer Managed by Active Surveillance
- 31 December 2008
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 54 (6), 1297-1305
- https://doi.org/10.1016/j.eururo.2008.02.039
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Prostate‐specific antigen velocity in untreated, localized prostate cancerBJU International, 2007
- Predictors of Histological Disease Progression in Untreated, Localized Prostate CancerJournal of Urology, 2007
- Comparison of Free and Total Forms of Serum Human Kallikrein 2 and Prostate-Specific Antigen for Prediction of Locally Advanced and Recurrent Prostate CancerClinical Chemistry, 2007
- Detection of Life-Threatening Prostate Cancer With Prostate-Specific Antigen Velocity During a Window of CurabilityJNCI Journal of the National Cancer Institute, 2006
- Long-term outcome among men with conservatively treated localised prostate cancerBritish Journal of Cancer, 2006
- Nomograms for prostate cancer—is their use evidence-based?Nature Reviews Endocrinology, 2005
- Use of Prostate-Specific Antigen (PSA) Isoforms for the Detection of Prostate Cancer in Men with a PSA Level of 2–10 ng/ml: Systematic Review and Meta-AnalysisEuropean Urology, 2005
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerThe New England Journal of Medicine, 2005
- Predictors of Treatment After Initial Surveillance in Men With Prostate Cancer: Results From CaPSUREJournal of Urology, 2003
- Can Prostate Specific Antigen Derivatives and Pathological Parameters Predict Significant Change in Expectant Management Criteria for Prostate Cancer?Journal of Urology, 2003